Your browser doesn't support javascript.
loading
Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.
Friedrich, Sven O; Rachow, Andrea; Saathoff, Elmar; Singh, Kasha; Mangu, Chacha D; Dawson, Rodney; Phillips, Patrick Pj; Venter, Amour; Bateson, Anna; Boehme, Catharina C; Heinrich, Norbert; Hunt, Robert D; Boeree, Martin J; Zumla, Alimuddin; McHugh, Timothy D; Gillespie, Stephen H; Diacon, Andreas H; Hoelscher, Michael.
Afiliação
  • Friedrich SO; Division of Medical Physiology, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Rachow A; National Institute of Medical Research-Mbeya Medical Research Centre, Mbeya, Tanzania; Division of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich (LMU), Munich, Germany; DZIF German Centre for Infection Research, Munich, Germany.
  • Saathoff E; Division of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich (LMU), Munich, Germany.
  • Singh K; Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, London, UK.
  • Mangu CD; National Institute of Medical Research-Mbeya Medical Research Centre, Mbeya, Tanzania.
  • Dawson R; Division of Pulmonology, Department of Medicine, University of Cape Town Lung Institute, Groote Schuur Hospital, Cape Town, South Africa.
  • Phillips PP; Medical Research Centre (MRC) Clinical Trials Unit, London, UK.
  • Venter A; MRC Centre for Molecular and Cellular Biology, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Bateson A; Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, London, UK.
  • Boehme CC; Foundation of Innovative New Diagnostics, Geneva, Switzerland.
  • Heinrich N; Division of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich (LMU), Munich, Germany.
  • Hunt RD; Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, London, UK.
  • Boeree MJ; Radboud University Nijmegen Medical Centre/UCCZ Dekkerswald, Nijmegen.
  • Zumla A; Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, London, UK.
  • McHugh TD; Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, London, UK.
  • Gillespie SH; University of St Andrews School of Medicine, North Haugh, St Andrews, Scotland, UK. Electronic address: shg3@st-andrews.ac.uk.
  • Diacon AH; Division of Medical Physiology, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Hoelscher M; Division of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich (LMU), Munich, Germany; DZIF German Centre for Infection Research, Munich, Germany.
Lancet Respir Med ; 1(6): 462-70, 2013 Aug.
Article em En | MEDLINE | ID: mdl-24429244

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escarro / Tuberculose Pulmonar / Antituberculosos Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escarro / Tuberculose Pulmonar / Antituberculosos Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2013 Tipo de documento: Article